Financials
Financial year 2024
SIGA PHARM from Ukkel, company number BE0801934929, closed financial year 2024 with a result of € 27,045 after tax. For that financial year SIGA PHARM recorded a gross margin of € 38,501 and equity of € 29,045. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2025.
€ 29,045
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 27,045
Profit after tax over the fiscal year.
€ 3,821
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 27,045.
People and assets in 2024
€ 2,393
Book value of vehicles, furniture and equipment.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 389
Supplier invoices still open on the last day of the fiscal year.
€ 16,759
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to SIGA PHARM?
What happened at SIGA PHARM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 27,045. filed late Source: NBB ↗
- New establishment in Ukkel. KBO
- Start of the company according to the CBE. KBO
In short
Paid € 8,000 in corporate taxes since 2024.
A new publication or filing at SIGA PHARM? We notify you, reason included.
Follow SIGA PHARMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Establishments
Establishment units
Physical locations of this company
Alsembergsesteenweg 432 box 9
1180 Ukkel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →LEASCOM
R.V.D. International
BRUXY
€ 24,345 gross margin · 2025
PHARMACIE DU ROOSENDAEL
€ 215,355 gross margin · 2025
ELA SERVICES
€ 47,470 gross margin · 2024
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0801.934.929
- VAT number
- BE 0801.934.929
- Registered office
- Alsembergsesteenweg 432 bus 9, 1180 Ukkel
- Names & denominations
- SIGA PHARM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 May 2023
- Peppol
- Active · Active since 27 Jan 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Overige zakelijke dienstverlening, neg